Introducing FCR6-Brain: Measuring fear of cancer recurrence in brain tumor patients and their caregivers.

Sarah Ellen BraunKelcie D WillisSamantha N MladenFarah AslanzadehAutumn LanoyeJenna LangbeinMorgan ReidAshlee R Loughan

Published in: Neuro-oncology practice (2022)

The FCR6-Brain is the first validated instrument to assess FCR in this population and should be used to identify individuals at risk for FCR and guide development of future psychotherapeutic interventions. This study highlights the distinct characteristics of FCR in neuro-oncology. Symptoms of hypervigilance in PBT patients need further investigation.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
physical activity
resting state
brain injury